Research programme: serotonin 7 receptor agonists - Esteve

Drug Profile

Research programme: serotonin 7 receptor agonists - Esteve

Alternative Names: 5HT-7 ligands - Esteve

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Esteve
  • Class
  • Mechanism of Action Serotonin 7 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Insomnia; Major depressive disorder; Migraine; Pain; Psychiatric disorders; Urinary incontinence
  • Discontinued Anxiety disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Spain (PO)
  • 30 Oct 2006 Preclinical trials in Migraine in Spain (PO)
  • 30 Oct 2006 Preclinical trials in Urinary incontinence in Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top